Cutaneous metastases of visceral tumours: a review
- 571 Downloads
Up to 10% of all visceral malignancies develop cutaneous metastases. As cutaneous metastases are underestimated and underdiagnosed they can be a clinical challenge. The clinical appearance and patterns of distribution of cutaneous metastases, the characterisation of clinical outcomes and available therapeutic options are compiled.
Patients and methods
Literature (over the last 6 years) MESH in terms of cutaneous metastases was comprehensively evaluated. Characteristics from 92 available cases are elaborated and adjusted with terms (time unlimited) of published epidemiological reviews to single organs.
The broad clinical spectrum with differential diagnoses is displayed. An allocation of cutaneous metastases and a particular organ is not reliable. In 22% of all cases cutaneous metastases can lead to the diagnosis of an internal malignoma. The majority of cases reveal cutaneous metastases to emerge in a tumour-free interval in about 36 months, after a successful treatment of the primary tumour, most commonly along with other organ metastases. Probable survival turned out to be less than 12 months. Consistently with this end-stage condition, treatment aligns with rules of palliation. Local treatment of choice is excision. Only a minority of investigators attempted to come up with tumour-specific treatment strategies, and almost no randomised therapy studies can be presented.
A reference guide of cutaneous metastases is given; the clinical spectrum is adjusted to an actual status; state of the art of the treatment is accomplished. An epidemiological, improved registration and diagnostic work-up for targeted therapies in conjunction with dermatologists are favoured.
KeywordsDermatology Neoplasm metastasis Skin neoplasms Review (publication type) Therapeutics
Conflict of interest statement
There is no conflict of interest for any of the authors including any financial, personal or other relationships with other people or organizations within 3 years of beginning the work submitted that could inappropriately influence the work.
- Barry DN, Peyromaure M, Debre B et al (2004) Renal cancer presenting as an isolated cutaneous metastasis. Prog Urol 14:538–539Google Scholar
- Karamouzis MV, Ardavanis A, Alexopoulos A et al (2005) Multiple cutaneous acral metastases in a woman with breast adenocarcinoma treated with pegylated liposomal doxorubicin: incidental or aetiological association? Eur J Cancer Care (Engl) 14:267–271. doi: 10.1111/j.1365-2354.2005.00573.x Google Scholar
- Moll I, Moll R (2005) Kutane Metastasen—Klinik, Histopathologie und spezielle Marker. Akt Dermatol 31:541–548Google Scholar
- National Library of Medicine (2008) http://www.pubmed.gov. Accessed 17 May 2008
- Radny P (2006) Therapie bei Haut- und Weichteilmetastasen. In: Management des Melanoms, 1st edn. Springer Medizin Verlag, Heidelberg, pp 329–334Google Scholar
- Schwartz R (1995) Cutaneous metastatic disease. J Am Acad Dermatol 33:182Google Scholar
- Wollina U, Graefe T, Konrad H et al (2004) Cutaneous metastases of internal cancer. Acta Dermatovenerol Alp Panonica Adriat 13:79–84Google Scholar